BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20890249)

  • 1. Adverse drug reactions: part II.
    Wooten JM
    South Med J; 2010 Nov; 103(11):1138-45; quiz 1146-7. PubMed ID: 20890249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions: Part I.
    Wooten JM
    South Med J; 2010 Oct; 103(10):1025-8; quiz 1029. PubMed ID: 20818299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
    Gotta V; van den Anker J; Pfister M
    Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse drug reactions in children].
    Jaffan L; Läer S
    Ther Umsch; 2011 Jan; 68(1):34-40. PubMed ID: 21184392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions: trends in a tertiary care hospital.
    Rehan HS; Chopra D; Sah RK; Mishra R
    Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data.
    Endrikat J; Schwenke C; Prince MR
    Clin Radiol; 2015 Jul; 70(7):743-51. PubMed ID: 25933719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Life-threatening drug reactions in children].
    Leśniak M; Woron J; Czarnobilska E
    Przegl Lek; 2013; 70(12):1003-7. PubMed ID: 24720116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
    Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)].
    Hoigné R; Sollberger J; Zoppi M; Müller U; Hess T; Fritschy D; Stocker F; Maibach R
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1854-7. PubMed ID: 6515386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
    Egger SS; Krähenbühl S; Schlienger RG
    Schweiz Monatsschr Zahnmed; 2005; 115(12):1209-18. PubMed ID: 16408825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse drug reactions and prescription errors: morbi-mortality].
    Chaio S; Toibaro J; Valicenti P; Saidón P
    Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.
    Fabiano V; Mameli C; Zuccotti GV
    Expert Opin Drug Saf; 2012 Jan; 11(1):95-105. PubMed ID: 21548838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.
    Pellegrino P; Carnovale C; Cattaneo D; Perrone V; Antoniazzi S; Pozzi M; Napoleone E; Filograna MR; Clementi E; Radice S
    Health Policy; 2013 Nov; 113(1-2):216-20. PubMed ID: 24012386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the assessment of the severity on the frequency of adverse drug reactions (ADRs).
    Zilleruelo I; Espinoza E; Ruiz I
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):328-33. PubMed ID: 3623738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.